Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
276.94
-2.50 (-0.89%)
Oct 3, 2025, 4:00 PM EDT - Market closed
Labcorp Holdings Revenue
Labcorp Holdings had revenue of $3.53B in the quarter ending June 30, 2025, with 9.51% growth. This brings the company's revenue in the last twelve months to $13.48B, up 7.98% year-over-year. In the year 2024, Labcorp Holdings had annual revenue of $13.01B with 6.97% growth.
Revenue (ttm)
$13.48B
Revenue Growth
+7.98%
P/S Ratio
1.72
Revenue / Employee
$192,626
Employees
70,000
Market Cap
23.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13.01B | 847.30M | 6.97% |
Dec 31, 2023 | 12.16B | 297.70M | 2.51% |
Dec 31, 2022 | 11.86B | -1.27B | -9.68% |
Dec 31, 2021 | 13.14B | -842.40M | -6.03% |
Dec 31, 2020 | 13.98B | 2.42B | 20.98% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
LH News
- 4 days ago - Labcorp Announces Collaboration with Roche to Advance Digital Pathology Capabilities - PRNewsWire
- 9 days ago - Labcorp to Announce Third Quarter Financial Results on October 28, 2025 - PRNewsWire
- 19 days ago - Labcorp Completes Acquisition of Select Assets of BioReference Health's Innovative Oncology and Related Clinical Testing Services Businesses - PRNewsWire
- 25 days ago - Labcorp Holdings Inc. (LH) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 5 weeks ago - Labcorp to Speak at the Morgan Stanley 23rd Annual Global Healthcare Conference - PRNewsWire
- 6 weeks ago - Labcorp Launches First FDA-Cleared Blood Test for Alzheimer's Disease - PRNewsWire
- 2 months ago - Labcorp Introduces Test Finder, a First-of-Its-Kind Generative AI Tool to Simplify Lab Test Search - PRNewsWire
- 2 months ago - Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU - PRNewsWire